GALT (P07902) variants and mutations
GALT (also known as P07902) is a human protein-coding gene encoding a galactose-1-phosphate uridylyltransferase protein. It converts galactose-1-phosphate and UDP-glucose into glucose-1-phosphate and UDP-galactose in the Leloir pathway. Biallelic deficiency causes classic galactosemia, in which dietary galactose can lead to neonatal liver failure, sepsis risk, cataracts, and long-term complications. This analysis covers 787 GALT variants and mutations. Of these, 82% have computational variant effect predictions. Disease context includes classic galactosemia, galactosemia, and hereditary disease. Example GALT variants include M1L, M1R, and M1T.
Variant analysis overview
- Gene: GALT
- Protein: P07902
- UniProt accession: P07902
- Organism: Homo sapiens
- Variants analyzed: 787
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 605 unspecified-consequence records; 5 stop-gained variants; 68 synonymous variants; 78 missense variants; 15 frameshift variants; 4 splice-region variants; 3 in-frame deletions; 1 protein altering variant; 8 substitution
- Prediction scores: 642 variants have prediction scores (82% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: classic galactosemia, galactosemia, hereditary disease, juvenile amyotrophic lateral sclerosis, autosomal recessive distal spinal muscular atrophy 2, primary ovarian failure, carbohydrate metabolism disease, Disorder of carbohydrate metabolism, glaucoma, asthma, hyperinsulinemic hypoglycemia, familial, 4, cataract.
Protein structure and variant hotspots
- Protein features: 12 binding sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable GALT variants
Examples include M1L, M1R, M1T, M1V, S2L, S2*, S2S, R3C. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1L (p.Met1Leu), rs111033639, ClinGen CA373278153, ClinVar RCV003831837, MetaLR 0.92, MetaSVM 1.08, Pathogenic/Likely pathogenic, Galactosemia; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- M1R (p.Met1Arg), rs771702963, ClinGen CA5035982, ClinVar RCV001004538, MetaLR 0.92, MetaSVM 0.72, Pathogenic, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- M1T (p.Met1Thr), rs771702963, ClinGen CA373278158, ClinVar RCV000988176, MetaLR 0.92, MetaSVM 0.72, Pathogenic/Likely pathogenic, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- M1V (p.Met1Val), rs111033639, ClinGen CA259306, ClinVar RCV000022038, ClinVar RCV006272362, MetaLR 0.92, MetaSVM 1.08, Uncertain significance, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- S2L (p.Ser2Leu), ExAC rs772918156, TOPMed rs772918156, gnomAD rs772918156, REVEL 0.41, CADD 23.30
- S2* (p.Ser2Ter), gnomAD 9-34646709-C-A, CADD 35.00
- S2S (p.Ser2Ser), rs1410764100, gnomAD 9-34646710-G-A, CADD 11.90
- R3C (p.Arg3Cys), TOPMed rs1821109915, gnomAD rs1821109915, REVEL 0.46, CADD 19.30
- R3H (p.Arg3His), gnomAD rs1184899566
- R3P (p.Arg3Pro), gnomAD 9-34646712-G-C, REVEL 0.39, AlphaMissense 0.08
- S4G (p.Ser4Gly), gnomAD 9-34646714-A-G, REVEL 0.30, CADD 8.21
- S4R (p.Ser4Arg), gnomAD 9-34646716-T-G, REVEL 0.32, CADD 14.80
- S4* (p.Ser4Ter), gnomAD 9-34647219-C-G, AlphaMissense 0.97, MetaLR 0.97
- G5R (p.Gly5Arg), gnomAD rs1402006997, REVEL 0.48, CADD 22.80
- G5E (p.Gly5Glu), rs1269693119, gnomAD 9-34647237-G-A, CADD 13.80
- T6A (p.Thr6Ala), 1000Genomes rs573516675, ExAC rs573516675, gnomAD rs573516675, REVEL 0.41, CADD 3.13
- T6T (p.Thr6Thr), rs765932955, gnomAD 9-34646722-C-T, CADD 1.33
- T6I (p.Thr6Ile), rs777562713, gnomAD 9-34647213-C-T, CADD 11.50
- D7Y (p.Asp7Tyr), rs1469998825, ClinGen CA373278218, ClinVar RCV001863384, gnomAD rs1469998825, REVEL 0.35, CADD 17.40, Uncertain significance, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- D7I (p.Asp7Ile), rs111033638, gnomAD 9-34646720-AC-A, CADD 18.90
- D7G (p.Asp7Gly), gnomAD 9-34646724-A-G, REVEL 0.40, CADD 1.43
- P8L (p.Pro8Leu), Ensembl rs1821110462, Uncertain significance, Galactosemia
- P8R (p.Pro8Arg), gnomAD 9-34646727-C-G, REVEL 0.37, CADD 15.40
- P8P (p.Pro8Pro), rs147803976, gnomAD 9-34646728-T-G, CADD 5.21
- Q9* (p.Gln9Ter), rs111033848, ClinGen CA259309, ClinVar RCV000022040, Ensembl rs111033848, CADD 33.00, Likely pathogenic, in GALAC1
- Q9E (p.Gln9Glu), NCI-TCGA Cosmic COSV1011, Variant assessed as somatic; moderate impact., in GALAC1
- Q9H (p.Gln9His), rs111033637, ClinGen CA259311, ClinVar RCV000022041, UniProt VAR 068531, AlphaMissense 0.12, MetaLR 0.93, Pathogenic, in GALAC1
- Q9L (p.Gln9Leu), ExAC rs764584693, gnomAD rs764584693, REVEL 0.41, AlphaMissense 0.09
- Q9P (p.Gln9Pro), gnomAD 9-34646730-A-C, REVEL 0.41, AlphaMissense 0.07
- Q10* (p.Gln10Ter), rs2492858066, ClinVar RCV004576654, Likely pathogenic
- Q10Q (p.Gln10Gln), rs139122460, gnomAD 9-34646734-A-G, CADD 10.30
- R11C (p.Arg11Cys), TOPMed rs1172080423, REVEL 0.37, AlphaMissense 0.08, Uncertain significance
- R11G (p.Arg11Gly), rs1172080423, ClinGen CA373278251, ClinVar RCV003035981, TOPMed rs1172080423, AlphaMissense 0.08, MetaLR 0.93, Uncertain significance, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- R11H (p.Arg11His), rs757632977, ClinGen CA5035990, ClinVar RCV000686259, ClinVar RCV001276327, REVEL 0.36, CADD 16.00, Uncertain significance, Inborn genetic diseases; Deficiency of UDPglucose-hexose-1-phosphate uridylyltra
- Q12R (p.Gln12Arg), TOPMed rs1821111136
- Q13* (p.Gln13Ter), rs781347467, ClinGen CA373278271, ClinVar RCV003461645, AlphaMissense 0.08, MetaLR 0.91, Likely pathogenic
- Q13E (p.Gln13Glu), ExAC rs781347467, TOPMed rs781347467, gnomAD rs781347467
- Q13K (p.Gln13Lys), ExAC rs781347467, TOPMed rs781347467, gnomAD rs781347467
- Q13L (p.Gln13Leu), gnomAD 9-34646742-A-T, REVEL 0.47, CADD 15.80
- Q13H (p.Gln13His), gnomAD 9-34646743-G-T, REVEL 0.45, CADD 22.50
- A14P (p.Ala14Pro), ExAC rs750690794, TOPMed rs750690794, gnomAD rs750690794, REVEL 0.42, CADD 19.80, Uncertain significance
- A14T (p.Ala14Thr), rs750690794, ClinGen CA5035992, ClinVar RCV003116122, ExAC rs750690794, REVEL 0.39, CADD 17.80, Uncertain significance, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- A14V (p.Ala14Val), TOPMed rs1821111452, REVEL 0.44, AlphaMissense 0.11
- A14A (p.Ala14Ala), gnomAD 9-34646746-G-A, CADD 12.10
- S15L (p.Ser15Leu), rs759270191, ClinGen CA5035994, ClinVar RCV001462608, ClinVar RCV002271654, REVEL 0.40, CADD 19.60, Conflicting interpretations, Inborn genetic diseases; not specified; Deficiency of UDPglucose-hexose-1-phosph
- S15T (p.Ser15Thr), ExAC rs756267534, TOPMed rs756267534, REVEL 0.39, CADD 10.80
- S15F (p.Ser15Phe), rs960526230, gnomAD 9-34647243-C-T, CADD 7.71
- S15N (p.Ser15Asn), rs748732979, gnomAD 9-34647258-G-A, CADD 23.30
- E16Q (p.Glu16Gln), NCI-TCGA Cosmic COSV1011, Variant assessed as somatic; moderate impact.
- E16V (p.Glu16Val), Ensembl rs1821111703
- E16G (p.Glu16Gly), gnomAD 9-34646751-A-G, REVEL 0.45, CADD 22.90
- E16E (p.Glu16Glu), gnomAD 9-34646752-G-A, CADD 10.20
- A17V (p.Ala17Val), ExAC rs749374402, gnomAD rs749374402, REVEL 0.36, CADD 15.30
- A17G (p.Ala17Gly), gnomAD 9-34646754-C-G, REVEL 0.37, CADD 17.70
- A17A (p.Ala17Ala), gnomAD 9-34646755-G-C, CADD 11.10
- D18G (p.Asp18Gly), Ensembl rs2132340854
- A19D (p.Ala19Asp), TOPMed rs1179634471
- A19P (p.Ala19Pro), rs545621674, ClinGen CA5035996, ClinVar RCV003129480, 1000Genomes rs545621674, REVEL 0.52, AlphaMissense 0.09, Uncertain significance, not provided
- A19T (p.Ala19Thr), gnomAD 9-34646759-G-A, REVEL 0.45, AlphaMissense 0.07
- A19A (p.Ala19Ala), rs1821111990, gnomAD 9-34646761-C-G, CADD 11.80
- A20G (p.Ala20Gly), ExAC rs779003828, TOPMed rs779003828, gnomAD rs779003828, REVEL 0.35, AlphaMissense 0.09
- A22T (p.Ala22Thr), ExAC rs748028316, gnomAD rs748028316, REVEL 0.41, CADD 14.20
- A22P (p.Ala22Pro), gnomAD 9-34646768-G-C, REVEL 0.38, CADD 16.70
- T23A (p.Thr23Ala), rs111033635, UniProt VAR 068532, Ensembl rs111033635, AlphaMissense 0.06, MetaLR 0.80, Pathogenic, in GALAC1
- T23N (p.Thr23Asn), rs1365354002, ClinGen CA373278367, ClinVar RCV001580708, TOPMed rs1365354002, REVEL 0.40, CADD 19.50, Uncertain significance, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- T23I (p.Thr23Ile), gnomAD 9-34646772-C-T, REVEL 0.45, CADD 21.30
- R25P (p.Arg25Pro), rs886042099, ClinGen CA10603808, ClinVar RCV000316707, Ensembl rs886042099, AlphaMissense 0.19, MetaLR 0.90, Uncertain significance, not provided
- R25W (p.Arg25Trp), gnomAD rs1821112297, REVEL 0.63, CADD 26.40
- A26E (p.Ala26Glu), gnomAD rs1235159078, REVEL 0.59, CADD 25.00
- N27K (p.Asn27Lys), ExAC rs771930483, gnomAD rs771930483, REVEL 0.32, CADD 20.70
- N27N (p.Asn27Asn), gnomAD 9-34646785-C-T, CADD 16.90
- D28H (p.Asp28His), rs111033636, UniProt VAR 068533, Ensembl rs111033636, AlphaMissense 0.17, MetaLR 0.95, Pathogenic, in GALAC1
- D28N (p.Asp28Asn), rs111033636, ClinGen CA261025, ClinVar RCV000031852, Ensembl rs111033636, REVEL 0.57, AlphaMissense 0.17, Uncertain significance, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- D28Y (p.Asp28Tyr), rs111033636, ClinVar RCV005238451, UniProt VAR 002548, Ensembl rs111033636, REVEL 0.88, AlphaMissense 0.17, Pathogenic, in GALAC1
- H29R (p.His29Arg), rs2132341442, ClinGen CA373278465, ClinVar RCV001998181, Ensembl rs2132341442, REVEL 0.96, AlphaMissense 0.62, Likely pathogenic, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- H29Y (p.His29Tyr), rs2492861309, ClinGen CA373278461, ClinVar RCV003404651, Uncertain significance, GALT-related disorder
- Q30H (p.Gln30His), Ensembl rs111033834
- Q30P (p.Gln30Pro), TOPMed rs1288345141, gnomAD rs1288345141, REVEL 0.67, AlphaMissense 0.92
- Q30Q (p.Gln30Gln), gnomAD 9-34647096-G-A, CADD 13.10
- H31N (p.His31Asn), rs111033643, ClinGen CA259320, ClinVar RCV001826488, ClinVar RCV003502508, AlphaMissense 0.83, MetaLR 0.99, Likely pathogenic
- H31H (p.His31His), gnomAD 9-34647099-T-C, CADD 13.50
- I32N (p.Ile32Asn), rs111033644, UniProt VAR 002549, Ensembl rs111033644, AlphaMissense 0.43, MetaLR 0.96, Pathogenic, in GALAC1
- I32L (p.Ile32Leu), gnomAD 9-34647100-A-C, REVEL 0.41, CADD 22.40
- I32V (p.Ile32Val), gnomAD 9-34647100-A-G, REVEL 0.42, CADD 19.70
- I32T (p.Ile32Thr), gnomAD 9-34647101-T-C, REVEL 0.64, CADD 24.30
- I32I (p.Ile32Ile), gnomAD 9-34647102-C-T, CADD 12.10
- R33H (p.Arg33His), rs111033829, ClinGen CA259323, ClinVar RCV000022051, UniProt VAR 068534, AlphaMissense 0.91, MetaLR 1.00, Pathogenic, in GALAC1
- R33P (p.Arg33Pro), UniProt VAR 072793, Pathogenic, in GALAC1
- R33R (p.Arg33Arg), gnomAD 9-34647105-C-A, CADD 16.30
- Y34H (p.Tyr34His), TOPMed rs111033836, Pathogenic, in GALAC1
- Y34N (p.Tyr34Asn), rs111033836, ClinGen CA259324, ClinVar RCV000022052, ClinVar RCV000726020, REVEL 0.97, CADD 32.00, Pathogenic, in GALAC1
- P36L (p.Pro36Leu), rs111033645, ClinGen CA241292, ClinVar RCV000175533, ClinVar RCV005430938, REVEL 0.91, CADD 29.30, Uncertain significance
- P36P (p.Pro36Pro), rs1362198825, gnomAD 9-34647114-G-C, CADD 14.00
- L37R (p.Leu37Arg), ExAC rs774933597, gnomAD rs774933597, REVEL 0.97, CADD 32.00
- L37L (p.Leu37Leu), gnomAD 9-34647115-C-T, CADD 14.90
- L37H (p.Leu37His), rs528320335, gnomAD 9-34647216-T-A, CADD 12.50
- Q38* (p.Gln38Ter), ExAC rs762421661, gnomAD rs762421661
- Q38P (p.Gln38Pro), rs111033646, ClinGen CA259325, ClinVar RCV003062202, UniProt VAR 002550, AlphaMissense 0.61, MetaLR 0.93, Pathogenic, in GALAC1
- Q38Q (p.Gln38Gln), gnomAD 9-34647120-G-A, CADD 15.90
- D39Y (p.Asp39Tyr), TOPMed rs1324892935, gnomAD rs1324892935, REVEL 0.93, CADD 32.00
- E40D (p.Glu40Asp), TOPMed rs1191417781
- E40K (p.Glu40Lys), rs886042060, ClinGen CA10603758, ClinVar RCV000591981, Ensembl rs886042060, REVEL 0.72, CADD 29.50, Pathogenic, not provided
- W41R (p.Trp41Arg), gnomAD rs1450493685, REVEL 0.96, CADD 32.00
- V42A (p.Val42Ala), Ensembl rs1587237002, Pathogenic/Likely pathogenic, not specified; Galactosemia; Deficiency of UDPglucose-hexose-1-phosphate uridyly
- V42G (p.Val42Gly), Ensembl rs1587237002
- V42L (p.Val42Leu), Ensembl rs1564100650
- V42M (p.Val42Met), gnomAD 9-34647130-G-A, REVEL 0.94, CADD 29.70
- V42V (p.Val42Val), gnomAD 9-34647132-G-A, CADD 12.70
- L43L (p.Leu43Leu), rs767903479, gnomAD 9-34647135-G-T, CADD 10.90
- V44G (p.Val44Gly), NCI-TCGA Cosmic COSV1011, Ensembl rs1587237018, Variant assessed as somatic; moderate impact., in GALAC1
- V44L (p.Val44Leu), rs111033647, UniProt VAR 002551, Ensembl rs111033647, AlphaMissense 0.74, MetaLR 0.98, Pathogenic, in GALAC1
- V44M (p.Val44Met), rs111033647, ClinGen CA252845, ClinVar RCV000003795, UniProt VAR 002552, AlphaMissense 0.74, MetaLR 0.98, Pathogenic, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- S45* (p.Ser45Ter), rs111033652, ClinGen CA373278589, ClinVar RCV000988177, Ensembl rs111033652, AlphaMissense 0.83, MetaLR 0.99, Pathogenic, in GALAC1
- S45L (p.Ser45Leu), rs111033652, ClinGen CA220416, ClinVar RCV000078214, ClinVar RCV001851992, REVEL 0.99, AlphaMissense 0.53, Pathogenic, in GALAC1
- S45P (p.Ser45Pro), rs2132341560, ClinGen CA373278586, ClinVar RCV001802722, Ensembl rs2132341560, AlphaMissense 0.97, MetaLR 0.99, Likely pathogenic, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- A46V (p.Ala46Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- H47D (p.His47Asp), rs886042074, ClinGen CA10603777, ClinVar RCV000322916, Ensembl rs886042074, AlphaMissense 0.82, MetaLR 0.99, Uncertain significance, not provided
- H47R (p.His47Arg), rs2132341581, ClinGen CA373278601, ClinVar RCV001420875, Ensembl rs2132341581, AlphaMissense 0.61, MetaLR 0.99, Uncertain significance, not specified
- H47Y (p.His47Tyr), gnomAD 9-34647145-C-T, REVEL 0.94, AlphaMissense 0.96
- H47H (p.His47His), rs2132341583, gnomAD 9-34647147-C-T, CADD 12.50
- R48C (p.Arg48Cys), rs886042088, ClinGen CA10603796, ClinVar RCV000273060, ClinVar RCV003463740, REVEL 0.96, AlphaMissense 0.99, Conflicting interpretations, not provided; not specified; Deficiency of UDPglucose-hexose-1-phosphate uridyly
- R48H (p.Arg48His), ExAC rs773683290, gnomAD rs773683290, REVEL 0.94, CADD 32.00
- R48L (p.Arg48Leu), rs773683290, ClinGen CA373278607, ClinVar RCV003331887, REVEL 0.95, CADD 32.00, Uncertain significance, not specified
- R48S (p.Arg48Ser), rs886042088, ClinGen CA373278604, ClinVar RCV002250006, TOPMed rs886042088, AlphaMissense 0.99, MetaLR 0.99, Pathogenic, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- R48R (p.Arg48Arg), rs371258192, gnomAD 9-34647150-C-T, CADD 15.20
- M49R (p.Met49Arg), Ensembl rs776666045
- R51L (p.Arg51Leu), rs111033648, ClinGen CA259330, ClinVar RCV001964239, UniProt VAR 002553, REVEL 0.98, CADD 29.70, Pathogenic, in GALAC1
- R51Q (p.Arg51Gln), rs111033648, ClinGen CA259331, ClinVar RCV000022061, UniProt VAR 023328, REVEL 0.96, CADD 31.00, Pathogenic/Likely pathogenic, Galactosemia; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- R51W (p.Arg51Trp), gnomAD 9-34647157-C-T, REVEL 0.94, AlphaMissense 0.90
- R51R (p.Arg51Arg), rs2132341618, gnomAD 9-34647159-G-A, CADD 13.00
- P52R (p.Pro52Arg), rs2132341621, ClinGen CA373278632, ClinVar RCV001526915, ClinVar RCV004793509, AlphaMissense 0.85, MetaLR 0.99, Conflicting interpretations, not specified; not provided; Deficiency of UDPglucose-hexose-1-phosphate uridyly
- P52T (p.Pro52Thr), gnomAD 9-34647160-C-A, REVEL 0.93, CADD 25.20
- P52H (p.Pro52His), gnomAD 9-34647161-C-A, REVEL 0.97, CADD 27.60
- W53R (p.Trp53Arg), rs1131691837, ClinGen CA373278634, ClinVar RCV000672826, ClinVar RCV005614438, REVEL 0.97, CADD 32.00, Uncertain significance, Galactosemia; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- Q54* (p.Gln54Ter), rs111033649, ClinVar RCV004800251, Ensembl rs111033649, CADD 36.00, Pathogenic
- Q54K (p.Gln54Lys), gnomAD 9-34647166-C-A, REVEL 0.51, CADD 22.40
- Q54Q (p.Gln54Gln), rs766778777, gnomAD 9-34647168-G-A, CADD 13.20
- G55C (p.Gly55Cys), rs111033654, ClinGen CA259334, ClinVar RCV000767304, UniProt VAR 002554, AlphaMissense 0.97, MetaLR 0.99, Pathogenic, in GALAC1
- G55D (p.Gly55Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact., in GALAC1
- G55S (p.Gly55Ser), gnomAD 9-34647169-G-A, REVEL 0.94, CADD 31.00
- G55V (p.Gly55Val), gnomAD 9-34647170-G-T, REVEL 0.98, CADD 29.70
- Q56H (p.Gln56His), gnomAD 9-34647174-A-T, REVEL 0.78, CADD 23.30
- V57A (p.Val57Ala), TOPMed rs1262476384
- V57M (p.Val57Met), gnomAD rs1426479143, REVEL 0.69, AlphaMissense 0.77
- V57E (p.Val57Glu), gnomAD 9-34647176-T-A, REVEL 0.60, CADD 25.30
- E58D (p.Glu58Asp), NCI-TCGA Cosmic COSV6659, Variant assessed as somatic; moderate impact.
- E58K (p.Glu58Lys), rs1554709147, ClinGen CA373278670, ClinVar RCV000589593, ClinVar RCV001276261, AlphaMissense 0.77, MetaLR 0.99, Uncertain significance, not provided
- E58V (p.Glu58Val), rs2492861943, ClinGen CA373278673, ClinVar RCV002609219, ClinVar RCV004823045, Conflicting interpretations, not provided; Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- E58E (p.Glu58Glu), rs754140417, gnomAD 9-34647180-G-A, CADD 11.40
- P59A (p.Pro59Ala), ExAC rs755200200, gnomAD rs755200200, REVEL 0.53, AlphaMissense 0.08
- P59H (p.Pro59His), 1000Genomes rs139056441, ESP rs139056441, ExAC rs139056441, TOPMed rs139056441, REVEL 0.54, CADD 23.40, Uncertain significance, Inborn genetic diseases; Deficiency of UDPglucose-hexose-1-phosphate uridylyltra
- P59R (p.Pro59Arg), 1000Genomes rs139056441, ESP rs139056441, ExAC rs139056441, TOPMed rs139056441, REVEL 0.59, CADD 22.40, Uncertain significance, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase; Inborn genetic
- P59P (p.Pro59Pro), gnomAD 9-34647183-C-T, CADD 13.00
- Q60H (p.Gln60His), rs1554709148, gnomAD 9-34647185-AG-A, CADD 21.40
- L61R (p.Leu61Arg), gnomAD 9-34647188-T-G, REVEL 0.62, AlphaMissense 0.08
- L62M (p.Leu62Met), rs1800461, ClinGen CA116378, ClinVar RCV000003796, UniProt VAR 002555, AlphaMissense 0.10, MetaLR 0.91, Benign, GALT POLYMORPHISM
- L62L (p.Leu62Leu), rs1821124496, gnomAD 9-34647192-G-T, AlphaMissense 0.15, MetaLR 0.74
- K63N (p.Lys63Asn), TOPMed rs1482410758
- T64I (p.Thr64Ile), gnomAD rs1320577685, REVEL 0.63, CADD 23.30
- T64T (p.Thr64Thr), rs2132341711, gnomAD 9-34647198-A-T, CADD 10.80
- V65A (p.Val65Ala), rs1211267776, ClinGen CA373278716, ClinVar RCV003038273, Ensembl rs1211267776, REVEL 0.67, CADD 25.30, Uncertain significance, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- V65L (p.Val65Leu), TOPMed rs1257918261, REVEL 0.58, CADD 20.90
- V65M (p.Val65Met), TOPMed rs1257918261
- P66H (p.Pro66His), rs111033656, ClinGen CA259335, ClinVar RCV000767308, ESP rs111033656, AlphaMissense 0.20, MetaLR 0.99, Uncertain significance
- P66L (p.Pro66Leu), rs111033656, ClinGen CA259337, ClinVar RCV000022066, ClinVar RCV000767307, REVEL 0.91, AlphaMissense 0.20, Uncertain significance
- P66S (p.Pro66Ser), TOPMed rs1317678108, REVEL 0.92, AlphaMissense 0.19
- R67C (p.Arg67Cys), rs111033658, ClinGen CA259339, ClinVar RCV000022067, ClinVar RCV000723719, REVEL 0.83, AlphaMissense 0.08, Pathogenic, in GALAC1
- R67H (p.Arg67His), rs758430398, ClinGen CA312560, NCI-TCGA Cosmic COSV6659, ClinVar RCV000634556, REVEL 0.90, CADD 27.00, Pathogenic/Likely pathogenic, Galactosemia; not provided; Deficiency of UDPglucose-hexose-1-phosphate uridylyl
- R67R (p.Arg67Arg), gnomAD 9-34647207-C-T, CADD 14.60
- H68P (p.His68Pro), rs193922247, ClinGen CA260400, ClinVar RCV000029806, ClinVar RCV000723445, AlphaMissense 0.10, MetaLR 0.94, Conflicting interpretations, not specified; not provided; Deficiency of UDPglucose-hexose-1-phosphate uridyly
- H68R (p.His68Arg), rs193922247, ClinGen CA373278729, ClinVar RCV000673177, gnomAD rs193922247, AlphaMissense 0.10, MetaLR 0.94, Uncertain significance, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- H68Y (p.His68Tyr), gnomAD 9-34647208-C-T, REVEL 0.54, CADD 17.30
- D69E (p.Asp69Glu), ExAC rs777562713, TOPMed rs777562713, gnomAD rs777562713
- D69G (p.Asp69Gly), gnomAD 9-34647212-A-G, REVEL 0.97, CADD 31.00
- P70L (p.Pro70Leu), gnomAD 9-34647215-C-T, REVEL 0.87, CADD 26.40
- L71F (p.Leu71Phe), 1000Genomes rs143994870, ESP rs143994870, ExAC rs143994870, TOPMed rs143994870, REVEL 0.51, CADD 24.70, Conflicting interpretations, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
- L71V (p.Leu71Val), 1000Genomes rs143994870, ESP rs143994870, ExAC rs143994870, TOPMed rs143994870, REVEL 0.54, CADD 22.70, Uncertain significance, not provided
- N72T (p.Asn72Thr), Ensembl rs1587237205
- N72Q (p.Asn72Gln), gnomAD 9-34647218-T-TC, CADD 24.40
- P73L (p.Pro73Leu), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10112, REVEL 0.96, CADD 25.00, Variant assessed as somatic; moderate impact.
Public GALT analysis runs
- GALT analysis run — GALT (787 variants) — completed 2026-08-19